Small account play with potential upcoming COVID catalystVaccine play: “Four vaccine candidates developed from VXRT's proprietary VAAST platform were assessed in mouse models and elicited a strong immune response.” (finance.yahoo.com)
Potential upcoming catalyst of a Phase 1 trial
As of last week, down 73% since the yearly high, has begun to reverse.
Very oversold on SlowStoch and has been for nearly a month
Below 100day SMA, only slightly above 200day SMA
Fib targets above, can use 0 fib below for stop loss.